Comment by
ramrodretired on Jan 26, 2023 1:00pm
Yes, Strange this time aday and NO volume! GOOD OR BAD?
Comment by
Legit62 on Jan 26, 2023 1:11pm
I put buy order in wouldnt take
Comment by
chry200030 on Jan 26, 2023 1:11pm
We are just waiting on FDA approval news now. Then we balst off. How long? a week, a month or 6 months., but it will come.
Comment by
wearethebest on Jan 26, 2023 1:20pm
Yes and if this was a US company it would already would have FDA approval.This is something that could save a lot of peoples lives and this is stupit on their part don't you think.
Comment by
fredgoodwinson on Jan 26, 2023 1:48pm
Agree WATB that this would have had approval by now if it were a US Company - probably some time ago (and first line in an early stage setting - a far bigger market). Whether this represents stupidity on their part is another matter.
Comment by
fredgoodwinson on Jan 26, 2023 4:58pm
This reasoning is in the context of a belief (which I strongly expressed at the time of the Clinical Protocol) that on the basis of the preclinical evidence TLD-1433 deserved to be trialled as a first-line treatment against early stage disease. Many lesser prospects had and have been permitted this setting.
Comment by
gebremeskel on Jan 26, 2023 5:18pm
Your belief about how TLD-1433 "deserved" to be trialled is beside the point. Did Theralase request this of the FDA and were not "permitted"? Or did Theralase submit the exact protocol they wanted to - for BCG-unresponsive NMIBC?
Comment by
enriquesuave on Jan 26, 2023 5:26pm
1st line would require a head to head trial of about 500 patients vs BCG in a randomized control trial. IMO. Much more lengthy and costly. Now we can potentially be used off label as a 1st line treatment, as well as for unresponsive BCG when hopefully approved. IMHO
Comment by
fredgoodwinson on Jan 26, 2023 6:50pm
If Enrique is correct as to the likely number of triallists required then accept that first-line/early stage would not have been feasible on the grounds of cost unless partnered.
Comment by
Rumpl3StiltSkin on Jan 26, 2023 5:41pm
So SF, At this point is it likely, or even possible, that TLT has applied for BTD. Or are we still likely waiting on clinicians to crunch the CR data on these first 25?
Comment by
ScienceFirst on Jan 26, 2023 5:46pm
Rump ... Very difficult to call. It all depends on how many people are involved in the process.
Comment by
enriquesuave on Jan 26, 2023 6:27pm
My guess is that if Dr Kulkarni who is the principal Investigator is presenting data mid February, then for sure by then we should have all stats needed for both FDA and Poster presentation. At least IMHO.
Comment by
ScienceFirst on Jan 26, 2023 6:33pm
Enrique ... After looking at the abstract conditions last night, there are some things that cannot be included. Like efficacy %s, for example. It's really regulated. Please refer to my post of yesterday, 01:04pm. Soon after Feb., we might be able to see what might look like this poster, if no ASCO rules prohibit that.
Comment by
gebremeskel on Jan 26, 2023 3:00pm
Sorry, that doesn't make any sense. Whether you're from Timbuctu or the good ol' USA, before you can get FDA approval you need to submit a minimum amount of clinical data as evidence of safety and efficacy. We haven't done that until just now! As my old pal Charlie Drake once sang, "If you want your boomerang to come back, well, first you've got to throw it!"
Comment by
Oilminerdeluxe on Jan 26, 2023 1:20pm
I suspect volume will be a bit different then...
Comment by
Kingpin68 on Jan 26, 2023 1:56pm
My small order was confirmed by my bank. Hasn't changed he volume from zero yet though.
Comment by
O12009 on Jan 26, 2023 2:38pm
No shares has traded on TSX but 28 thousand has traded on the other exchanges.
Comment by
RetiredREX on Jan 26, 2023 2:54pm
Any idea how to confirm whether halted or not?
Comment by
stocksnbonds458 on Jan 26, 2023 3:24pm
A lot of my small caps are not showing trading today, a glitch??